Home

Jenburkt Pharmaceuticals Ltd Quarterly Result

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

Net Profit - Last Quarter

₹ 6.51 Cr.

Last updated on: Apr 18, 2025

Jenburkt Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Jenburkt Pharmaceuticals Ltd for the Dec '24 is ₹ 38.47 crore as compare to the Sep '24 revenue of ₹ 43.07 crore.
  • This represent the decline of -10.68%a1# The ebitda of Jenburkt Pharmaceuticals Ltd for the Dec '24 is ₹ 10.4 crore as compare to the Sep '24 ebitda of ₹ 13.28 crore.
  • This represent the decline of -21.69%a1# The net profit of Jenburkt Pharmaceuticals Ltd for the Dec '24 is ₹ 6.51 crore as compare to the Sep '24 net profit of ₹ 9.6 crore.
  • This represent the decline of -32.19%a1#.

Jenburkt Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 20251124.7
16 Apr 20251133.45
15 Apr 20251092.3
11 Apr 20251042.85
09 Apr 20251009.85
08 Apr 20251018
07 Apr 20251014
04 Apr 20251045.65
03 Apr 20251071.3
02 Apr 20251040

Historical Revenue of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

29 Oct 24

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

05 Nov 24

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January

Read more

21 Jan 25

Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 20

Read more

29 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Jenburkt Pharmaceuticals Ltd

What key financial metrics are included in Jenburkt Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Jenburkt Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Jenburkt Pharmaceuticals Ltd announce its quarterly results?

Jenburkt Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Jenburkt Pharmaceuticals Ltd's quarterly performance impact its stock price?

Jenburkt Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Jenburkt Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Jenburkt Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Jenburkt Pharmaceuticals Ltd's quarterly results?

Yes, Jenburkt Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions